\u003cb\u003eReproductive hemostasis: A global approach to a global challenge\u003c/b\u003e \u003cp\u003eA hemostatic change in women through their reproductive lifetime is emerging as an issue of global importance. No wonder, as obstetric hemorrhage remains a major cause of maternal mortality in both developed and developing countries. Thrombophilias and pulmonary embolisms are a threat to maternal and fetal well-being.\u003c/p\u003e \u003cp\u003e\u003ci\u003eHemostasis and Thrombosis in Obstetrics \u0026 Gynecology\u003c/i\u003e provides a framework for assessing and managing hemostatic disorders in women. Written by an international team, it provides globally applicable guidelines for obstetric hematology. The practical approach to clinical management includes:\u003c/p\u003e \u003cul\u003e \u003cli\u003eHematologic changes in pregnancy\u003c/li\u003e \u003cli\u003eRed cell disorders\u003c/li\u003e \u003cli\u003ePlatelet disorders\u003c/li\u003e \u003cli\u003eInherited and acquired thrombophilia\u003c/li\u003e \u003cli\u003eInherited bleeding disorders\u003c/li\u003e \u003cli\u003ePostpartum hemorrhage\u003c/li\u003e \u003c/ul\u003e \u003cp\u003eBlood and bleeding disorders in women can be managed by obstetrician-gynecologists or hematologists, separately or together. \u003ci\u003eHemostasis and Thrombosis in Obstetrics \u0026 Gynecology\u003c/i\u003e provides specialists from both disciplines with the information necessary to manage their patients effectively.\u003c/p\u003e
nl
en